Article Details
Retrieved on: 2024-12-12 21:34:02
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
Samuel C. Blackman, Head of R&D at Day One Biopharmaceuticals, sold 30000 shares of common stock on December 10, 2024, at a weighted average price ...
Article found on: www.tradingview.com
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here